NGD-4715 is a drug that was developed by Neurogen, which acts as a selective, non-peptide antagonist at the melanin concentrating hormone receptor MCH1. In animal models, it has anxiolytic, antidepressant, and anorectic effects, and it has successfully passed Phase I of clinical trials in humans.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.